CVS - CVS Health Corporation

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
226,991,000
194,579,000
184,765,000
177,526,000
153,290,000
Cost of Revenue
187,463,000
163,041,000
156,220,000
148,669,000
126,762,000
Gross Profit
39,528,000
31,538,000
28,545,000
28,857,000
26,528,000
Operating Expenses
Research Development
-
-
-
-
-
Selling General and Administrative
-
-
-
18,519,000
17,074,000
Total Operating Expenses
27,880,000
21,368,000
19,028,000
18,519,000
17,074,000
Operating Income or Loss
11,648,000
10,170,000
9,517,000
10,338,000
9,454,000
Interest Expense
2,961,000
2,619,000
1,062,000
1,078,000
859,000
Total Other Income/Expenses Net
-2,156,000
-6,145,000
-208,000
-643,000
0
Income Before Tax
6,531,000
1,406,000
8,268,000
8,637,000
8,616,000
Income Tax Expense
2,205,000
2,002,000
1,637,000
3,317,000
3,386,000
Income from Continuing Operations
4,326,000
-596,000
6,631,000
5,320,000
5,230,000
Net Income
4,328,000
-594,000
6,622,000
5,317,000
5,237,000
Net Income available to common shareholders
4,325,000
-594,000
6,622,000
5,317,000
5,237,000
Reported EPS
Basic
-
-0.57
6.47
4.93
4.66
Diluted
-
-0.57
6.44
4.90
4.63
Weighted average shares outstanding
Basic
-
1,044,000
1,020,000
1,073,000
1,118,000
Diluted
-
1,044,000
1,024,000
1,079,000
1,126,000
EBITDA
-
6,743,000
11,996,000
12,813,000
11,546,000